---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-398561"
form_type: "8-K"
ticker: "CORT"
cik: "0001088856"
company_name: "CORCEPT THERAPEUTICS INC"
filed_at: "2026-09-23T12:15:05+00:00"
generated_at: "2026-09-23T12:21:13.178463+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Corcept: President of Endocrinology Sean Maduck retires Oct 1; Justin Gunn succeeds

## Summary
- Sean Maduck resigns as President, Endocrinology, effective Oct 1, 2026; no disagreement cited.
- Justin Gunn appointed President, Endocrinology, assumes role Oct 1; joins Executive Team, reports to CEO.
- Maduck signs consulting agreement at $57k/month through Sept 30, 2027; stock options keep vesting.
- Gunn joined Corcept July 2024 as VP Sales; led sales org for Lifyorli launch; 18 yrs at Gilead.
- Maduck will remain as senior commercial advisor to ensure smooth transition.

## SEC filing metadata
- accession: 0001193125-26-398561
- form_type: 8-K
- ticker: CORT
- cik: 0001088856
- company_name: CORCEPT THERAPEUTICS INC
- filed_at: 2026-09-23T12:15:05+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1088856/000119312526398561/0001193125-26-398561-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1088856/000119312526398561/d148256d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-398561
- JSON: https://secwatch.observer/filing/0001193125-26-398561.json
- Plain text: https://secwatch.observer/filing/0001193125-26-398561.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.